Randomized phase III trial of consolidation therapy with bortezomib-lenalidomide-Dexamethasone (VRd) vs bortezomib-dexamethasone (Vd) for patients with multiple myeloma who have completed a dexamethasone based induction regimen

S. J. Jacobus, S Vincent Rajkumar, M. Weiss, Alexander Keith Stewart, E. A. Stadtmauer, N. S. Callander, L. M. Dreosti, Martha Lacy, Rafael Fonseca

Research output: Contribution to journalArticle

5 Scopus citations
Original languageEnglish (US)
Pages (from-to)e448
JournalBlood Cancer Journal
Volume6
Issue number7
DOIs
StatePublished - Jul 29 2016

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this